10 Participants Needed

Supervised Exercise for Interstitial Cystitis

(IC/BPS Trial)

SJ
ML
RR
Overseen ByRory Ritts, MD
Age: 18+
Sex: Female
Trial Phase: Academic
Sponsor: Wake Forest University Health Sciences
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)
Approved in 1 JurisdictionThis treatment is already approved in other countries

Trial Summary

What is the purpose of this trial?

In this study, the efficacy of exercise to improve interstitial cystitis/bladder pain syndrome symptoms and quality of life will be investigated.

Do I have to stop taking my current medications for the trial?

The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.

Is supervised exercise generally safe for humans?

Supervised exercise is generally safe for humans, with few serious adverse events reported. Minor issues like muscle injuries can occur, but starting with low intensity and gradually increasing can help minimize risks.12345

How does the exercise regimen treatment for interstitial cystitis differ from other treatments?

The exercise regimen for interstitial cystitis is unique because it focuses on physical activity to potentially improve symptoms, unlike other treatments that may involve medication or surgical options. This approach is similar to exercise programs used in other conditions like interstitial lung disease, where exercise has been shown to improve exercise capacity and quality of life.678910

Research Team

Stephen J. Walker, PhD | Wake Forest ...

Stephen Walker, PhD

Principal Investigator

Wake Forest University Health Sciences

Eligibility Criteria

This trial is for English-speaking adult women aged 18-80 with a diagnosis of Interstitial Cystitis/Bladder Pain Syndrome (IC/BPS), confirmed by a specialist. Participants must be able to walk without assistance and tolerate moderate exercise, not pregnant, and free from certain conditions like bladder cancer or neurological disorders.

Inclusion Criteria

Must speak English
I am a woman aged 18-79 with diagnosed interstitial cystitis/bladder pain.
I have been diagnosed with bladder pain syndrome as per the American Urological Association Guidelines.
See 1 more

Exclusion Criteria

I can do moderate exercise and have been active for 90 minutes a week.
I can walk without any help from devices like canes or wheelchairs.
Pregnant women are not eligible for this study
See 1 more

Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Baseline Assessment

Participants complete baseline surveys and provide urine samples for biomarker analysis

1 week
1 visit (in-person)

Exercise Treatment

Participants undergo a supervised exercise program to relieve pain and improve symptoms

4 months
Weekly sessions (in-person)

Post-regimen Review

Participants are contacted to provide feedback on the exercise program and discuss continued exercise

1 week
1 contact (phone or email)

Follow-up

Participants are monitored for changes in symptoms and inflammatory biomarkers after the exercise program

4 weeks

Treatment Details

Interventions

  • Exercise regimen
Trial OverviewThe study tests whether a supervised exercise regimen can alleviate symptoms of IC/BPS and improve the quality of life in patients. It explores the effectiveness of physical activity as part of treatment for this chronic bladder condition.
Participant Groups
1Treatment groups
Experimental Treatment
Group I: Exercise treatment groupExperimental Treatment1 Intervention
This group will serve as both their own controls and study subjects for the experimental intervention. They will take surveys to record bladder symptoms and quality of life before undergoing exercise. They will then take the same surveys after exercise and their scores will be compared.

Find a Clinic Near You

Who Is Running the Clinical Trial?

Wake Forest University Health Sciences

Lead Sponsor

Trials
1,432
Recruited
2,506,000+

UNC Greensboro

Collaborator

Trials
1
Recruited
10+

University of North Carolina, Greensboro

Collaborator

Trials
33
Recruited
16,700+

Findings from Research

In a 1.5-year study involving 274 male veterans with cardiovascular disease risk factors, only one serious adverse event (atrial fibrillation) occurred, indicating that a progressive walking program can be safely recommended for high-risk individuals.
While minor musculoskeletal issues were common, over half of the reported adverse events were unrelated to the exercise program, highlighting the need for strategies to help individuals with chronic illnesses safely resume physical activity after any health setbacks.
Adverse events among high-risk participants in a home-based walking study: a descriptive study.Goodrich, DE., Larkin, AR., Lowery, JC., et al.[2022]
While there is a small overall increased risk of sudden cardiac death associated with physical exertion, it is important for physicians and patients to recognize that this risk can vary significantly among individuals.
To minimize risks during exercise, both physicians and patients should be well-informed about exercise risks, proper procedures, and self-monitoring techniques, emphasizing a gradual progression in exercise intensity.
Sudden cardiac death associated with exercise: the risk-benefit issue.Friedewald, VE., Spence, DW.[2019]
Out of 40 randomized controlled trials (RCTs) for rheumatoid arthritis (RA) and 25 for axial spondyloarthritis (axSpA), only 73% and 52% respectively reported information on harms, indicating a significant gap in the quality of reporting regarding adverse effects of supervised exercises.
Pain was the most commonly reported harm in both prespecified and non-prespecified outcomes, highlighting the need for better adherence to reporting guidelines like the CONSORT Harms 2022 Checklist to ensure a clearer understanding of the risks associated with exercise interventions.
Quality of reporting and nature of harms in clinical trials on supervised exercise in patients with rheumatoid arthritis or axial spondyloarthritis.Teuwen, MMH., Vlieland, TPMV., van Weely, SFE., et al.[2023]

References

Adverse events among high-risk participants in a home-based walking study: a descriptive study. [2022]
Sudden cardiac death associated with exercise: the risk-benefit issue. [2019]
Quality of reporting and nature of harms in clinical trials on supervised exercise in patients with rheumatoid arthritis or axial spondyloarthritis. [2023]
Is it safe to exercise during oncological treatment? A study of adverse events during endurance and resistance training - data from the Phys-Can study. [2021]
Screening, safety, and adverse events in physical activity interventions: collaborative experiences from the behavior change consortium. [2022]
Prehabilitation Exercise Before Urologic Cancer Surgery: A Systematic and Interdisciplinary Review. [2022]
Physical activity pattern of patients with interstitial lung disease compared to patients with COPD: A propensity-matched study. [2023]
Short term improvement in exercise capacity and symptoms following exercise training in interstitial lung disease. [2022]
Replicability of Physical Exercise Interventions in Lung Transplant Recipients; A Systematic Review. [2020]
10.United Statespubmed.ncbi.nlm.nih.gov
Exercise stress test interpretation for cardiac diagnosis and functional evaluation. [2008]